Closed call · historical reference

H2020-JTI-IMI2-2019-18-two-stage · Supporting the development of engineered T cells

Specific Challenge:Engineered T cells, including chimeric antigen receptor (CAR) and T-cell receptor (TCR) engineered T cells, combine features of cell therapy, gene therapy, and immunotherapy. With two distinct autologous CD19 CAR-T-cell therapies approved by Food and Drug Administration (FDA) in…